We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$111B
AUM Growth
+$10.5B
Cap. Flow
+$4.07B
Cap. Flow %
3.67%
Top 10 Hldgs %
16.5%
Holding
4,333
New
263
Increased
1,254
Reduced
2,016
Closed
548

Top Buys

Rank Stock Value
1
RAI
Reynolds American Inc
RAI
+$754M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$743M
3
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$526M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$384M
5
BTI icon
British American Tobacco
BTI
+$320M

Top Sells

Rank Stock Value
1
CTSH icon
Cognizant
CTSH
+$308M
2
AGN
Allergan plc
AGN
+$233M
3
BATS
Bats Global Markets, Inc.
BATS
+$190M
4
ACAS
American Capital Ltd
ACAS
+$186M
5
SLB icon
SLB Ltd
SLB
+$142M

Sector Composition

Rank Sector Weight
1 Financials 11.15%
2 Technology 9.78%
3 Healthcare 9.21%
4 Consumer Discretionary 6.76%
5 Consumer Staples 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARC
3551
DELISTED
ARC Document Solutions, Inc.
ARC
$45K ﹤0.01%
13,127
-7,895
-38% -$35.5K
CASC
3552
DELISTED
Cascadian Therapeutics, Inc.
CASC
$44K ﹤0.01%
+10,650
New +$44.8K
ACGN
3553
DELISTED
Aceragen Inc
ACGN
$43K ﹤0.01%
127
-206
-62% -$49.7K
SRGA
3554
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$42K ﹤0.01%
345
-469
-58% -$48.8K
ANTH
3555
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$42K ﹤0.01%
12,313
-1,866
-13% -$8.82K
CSLT
3556
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$40K ﹤0.01%
10,938
-11,138
-50% -$39.1K
NNA
3557
DELISTED
Navios Maritime Acquisition Corporation
NNA
$35K ﹤0.01%
1,381
-707
-34% -$19.4K
OPCH icon
3558
Option Care Health
OPCH
$3.76B
$33K ﹤0.01%
4,808
-7,412
-61% -$49K
SLS icon
3559
SELLAS Life Sciences
SLS
$1.99B
$33K ﹤0.01%
+37
New +$61.3K
GEN
3560
DELISTED
Genesis Healthcare, Inc.
GEN
$33K ﹤0.01%
12,842
-20,637
-62% -$74.1K
CIVI
3561
DELISTED
Civitas Resources
CIVI
$32K ﹤0.01%
249
-144
-37% -$28.9K
CPRX
3562
DELISTED
Catalyst Pharmaceutical
CPRX
$31K ﹤0.01%
16,050
+45
+0.3% +$57
IPI icon
3563
Intrepid Potash
IPI
$476M
$29K ﹤0.01%
1,713
-1,020
-37% -$19.7K
EGIO
3564
DELISTED
Edgio, Inc. Common Stock
EGIO
$29K ﹤0.01%
278
-436
-61% -$40.7K
AREX
3565
DELISTED
Approach Resources Inc.
AREX
$28K ﹤0.01%
+11,075
New +$32K
DRRX
3566
DELISTED
DURECT Corp
DRRX
$27K ﹤0.01%
2,638
-2,778
-51% -$29.7K
TNDM icon
3567
Tandem Diabetes Care
TNDM
$1.27B
$26K ﹤0.01%
+2,171
New +$47.5K
ASXC
3568
DELISTED
Asensus Surgical, Inc.
ASXC
$26K ﹤0.01%
1,643
-1,237
-43% -$21.4K
ATHX
3569
DELISTED
Athersys, Inc. Common Stock
ATHX
$21K ﹤0.01%
483
-861
-64% -$27.5K
CYTR
3570
DELISTED
CytRx Corp
CYTR
$17K ﹤0.01%
6,170
-5,749
-48% -$14.6K
NAK
3571
Northern Dynasty Minerals
NAK
$773M
$16K ﹤0.01%
11,500
+1,500
+15% +$3.08K
VANI icon
3572
Vivani Medical
VANI
$109M
$16K ﹤0.01%
555
+75
+16% +$2.87K
GEVO icon
3573
Gevo
GEVO
$353M
$12K ﹤0.01%
+520
New +$22K
BPTH
3574
DELISTED
Bio-Path Holdings Inc
BPTH
$11K ﹤0.01%
3
-5
-63% -$18.2K
TVIA
3575
DELISTED
TerraVia Holdings, Inc. Common Stock
TVIA
$11K ﹤0.01%
15,245
-27,660
-64% -$25.8K
141 142
143
144 145

Similar funds

CSIA
Charles Schwab Investment Advisory San Francisco, California $72.8B AUM 10.03% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
MNG
Manning & Napier Group Fairport, New York $8.76B AUM 23.27% 1-Year Est. Return
DPAM
Degroof Petercam Asset Management Brussels, Belgium $8.32B AUM
ICG
InterOcean Capital Group Nashville, Tennessee $4.19B AUM 26.29% 1-Year Est. Return
CW
Connectus Wealth Cincinnati, Ohio $3.66B AUM 26.47% 1-Year Est. Return

Credit Suisse's Q1 2017 Portfolio in Review

As of Q1 2017, Credit Suisse held 4,333 positions worth $111B, up 10% from $100B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse deployed $4.07B of net new capital in Q1 2017, opening 263 new positions and adding to 1,254 existing holdings. Its largest new stake was Qiagen: 1,270,687 shares worth $39M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Cognizant, an estimated $308M trimmed.

  • Credit Suisse's largest Q1 2017 buy was Qiagen: 1,270,687 shares worth $39M.
  • Credit Suisse added most to Reynolds American Inc in Q1 2017, an estimated $754M increase.
  • Credit Suisse's biggest Q1 2017 reduction was Cognizant, cutting an estimated $308M.
  • Credit Suisse fully exited Bats Global Markets, Inc. in Q1 2017, selling an estimated $190M.
  • Credit Suisse's ten largest holdings make up 17% of its $111B portfolio in Q1 2017.
  • Credit Suisse opened 263 new positions and closed 548 in Q1 2017.
  • Credit Suisse's portfolio value rose 10% quarter-over-quarter to $111B.

Based on Credit Suisse's 13F filing for Q1 2017, filed 15 May 2017.